-
Memantine HCl Market Analysis 2025 – Insights For Long-Term Investment & Planning
01 Jul 2025 12:32 GMT
The Business Research Company’s Memantine HCl Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, July 1, 2025 /EINPresswire.com/ -- Save 30% On All Global Market Reports With …
-
Billionaire Healthcare Investor Alex Denner’s Hedge Fund Has 75% of Its Assets in These 3 Stocks
17 Mar 2025 19:58 GMT
… investor, investing in well-known names such as Biogen (NASDAQ:BIIB) and Forest Laboratories … About This Article:
Billionaire healthcare investor Alex Denner’s Sarissa Capital … per stock.
Considering some billionaire investor hedge funds, that’s not …
-
Incyte Appoints Bill Meury Chief Executive Officer; Hervé Hoppenot to Retire
26 Jun 2025 11:44 GMT
… Vice President Commercial Operations, at Forest Laboratories prior to its acquisition by … ”) a biotechnology-focused, long-term investment adviser. Mr. Baker founded BBA … managers of a biotech-focused investment partnership at Tisch Financial Management …
-
Global Substance Abuse Treatment Market Report to 2030 - Featuring Alkermes, Allergan, Forest Laboratories and GlaxoSmithKline Among Others
30 Jan 2023 10:25 GMT
… key players and attractive investment proposition provide the readers …
What are the key investment pockets with respect to … and middle-income economies investing in the Substance Abuse … 4. Strategic Initiatives
10.3. Forest Laboratories, Inc.
10.3.1. …
-
Global Angina Pectoris Treatment Market Report 2022 to 2030 - Featuring Forest Laboratories, Gilead Sciences, GlaxoSmithKline, Novartis and Pfizer Among Others - ResearchAndMarkets.com
31 Jan 2023 14:56 GMT
…
F. Hoffmann-La Roche Ltd.
Forest Laboratories Inc.
Gilead Sciences, Inc.
GlaxoSmithKline … market?
What are the key investment pockets with respect to product … low and middle-income economies investing in the Angina Pectoris Treatment …
-
Biogen Appoints Chuck Triano as Head of Investor Relations
14 Mar 2023 12:39 GMT
… the Vice President of Investor Relations at Forest Laboratories, where he initiated the … pipeline programs; capital allocation and investment strategy. These forward-looking … rate fluctuations; risks relating to investment in our manufacturing capacity; …
-
Biogen Appoints Chuck Triano as Head of Investor Relations
14 Mar 2023 11:30 GMT
… the Vice President of Investor Relations at Forest Laboratories, where he initiated the … pipeline programs; capital allocation and investment strategy. These forward-looking … rate fluctuations; risks relating to investment in our manufacturing capacity; …
-
Alzheimer’s Disease Therapeutics and Diagnostics Market Top Companies, Business Growth & Investment Opportunities
23 Aug 2022 10:13 GMT
Alzheimers disease therapeutics and diagnostics market report provides a comprehensive analysis of the current market and estimations.
PORTLAND, OREGON, UNITED STATES, August 23, 2022 /EINPresswire.com/ -- Alzheimers is a neurodegenerative …
-
Antidepressant Drugs Market 2019 Precise Outlook – Allergan, Forest laboratories, Takeda, Novartis, Eli Lilly
08 Nov 2019 13:50 GMT
… help decision makers take sound investment evaluation. Besides, the report also … Companies are Pfizer, GlaxoSmithKline, Allergan, Forest laboratories, Takeda, Novartis, Eli Lilly and …
-
Schizophrenia Market to Witness Significant Growth by 2034 Across 7MM as New Therapies Enter Late-Stage Trials | DelveInsight
01 May 2025 17:00 GMT
New York, USA, May 01, 2025 (GLOBE NEWSWIRE) -- Schizophrenia Market to Witness Significant Growth by 2034 Across 7MM as New Therapies Enter Late-Stage Trials | DelveInsight The schizophrenia market size is expected to grow during the forecast period (2025 …
About
© 1995-2025